Research Article: Controlled siRNA Release of Nanopolyplex for Effective Targeted Anticancer Therapy in Animal Model
Introduction:
Small interfering RNA (siRNA)-based therapeutics represent a highly promising approach for cancer therapy. – However, the lack of safe and controllable siRNA delivery vehicles has significantly impeded its application and advancement. , Currently, only a limited number of siRNA drugs have obtained clinical approval from the FDA, and they are exclusively indicated for the treatment of hepatic disorders. , This is due to the challenge of achieving specific siRNA delivery exclusively to non-hepatic tissues. Even…
Read more